Impact of diabetes on COVID-19 prognosis beyond comorbidity burden: the CORONADO initiative
Bertrand Cariou, Matthieu Wargny, Anne‐Sophie Boureau, Sarra Smati, Blandine Tramunt, Rachel Desailloud, M. Lebeault, Coralie Amadou, Déborah Ancelle, Beverley Balkau, L. Bordier, Sophie Borot, Muriel Bourgeon, Olivier Bourron, Emmanuel Cosson, Martin Eisinger, Céline Gonfroy‐Leymarie, Jean‐Baptiste Julla, Lucien Marchand, Laurent Meyer, Dominique Seret‐Bégué, Dominique Simon, Ariane Sultan, Charles Thivolet, A. Vambergue, Camille Vatier, Patrice Winiszewski, Pierre‐Jean Saulnier, B. Bauduceau, Pierre Gourdy, Samy Hadjadj, on behalf of the CORONADO investigators
Topics & Concepts
MedicineComorbidityDiabetes mellitusInternal medicineCohortClinical endpointCohort studyCoronavirus disease 2019 (COVID-19)DiseaseClinical trialInfectious disease (medical specialty)EndocrinologyCOVID-19 Clinical Research StudiesHyperglycemia and glycemic control in critically ill and hospitalized patientsDiabetes and associated disorders